SEI INVESTMENTS CO - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 169 filers reported holding AXSOME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,272,723
-67.7%
61,135
-66.8%
0.01%
-65.2%
Q2 2023$13,241,424
+73.0%
184,267
+48.5%
0.02%
+64.3%
Q1 2023$7,655,043
-27.8%
124,109
-9.7%
0.01%
-41.7%
Q4 2022$10,602,830
+59.7%
137,467
-7.6%
0.02%
+60.0%
Q3 2022$6,638,000
+6.6%
148,789
-8.5%
0.02%
+15.4%
Q2 2022$6,227,000
+2.8%
162,586
+11.1%
0.01%
+8.3%
Q1 2022$6,059,000
+11.0%
146,363
+1.3%
0.01%
+20.0%
Q4 2021$5,461,000
+13.6%
144,454
-0.9%
0.01%0.0%
Q3 2021$4,808,000
-51.2%
145,792
-0.3%
0.01%
-54.5%
Q2 2021$9,859,000
+20.8%
146,180
+1.4%
0.02%
+4.8%
Q1 2021$8,163,000
-9.3%
144,170
+30.4%
0.02%
-8.7%
Q4 2020$9,004,000
+55.2%
110,521
+35.7%
0.02%
+35.3%
Q3 2020$5,801,000
+34.0%
81,423
+54.7%
0.02%
+30.8%
Q2 2020$4,330,000
+37.0%
52,627
-2.0%
0.01%
+8.3%
Q1 2020$3,160,000
-5.3%
53,715
+66.4%
0.01%
+20.0%
Q4 2019$3,337,000
+625.4%
32,283
+41.9%
0.01%
+900.0%
Q3 2019$460,000
-35.4%
22,748
-17.8%
0.00%
-50.0%
Q2 2019$712,000
+14.7%
27,658
-36.6%
0.00%0.0%
Q1 2019$621,00043,6450.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 758,794$53,032,11365.14%
Fairmount Funds Management LLC 2,341,238$163,629,12419.69%
Ally Bridge Group (NY) LLC 110,600$7,729,8349.07%
RTW INVESTMENTS, LP 4,489,596$313,777,8646.62%
SVB FINANCIAL GROUP 33,849$2,365,7074.45%
BVF INC/IL 2,131,100$148,942,5794.02%
Altium Capital Management LP 92,000$6,429,8803.35%
Tri Locum Partners LP 142,510$9,960,0243.18%
TANG CAPITAL MANAGEMENT LLC 320,000$22,364,8003.16%
Deep Track Capital, LP 1,140,745$79,726,6683.08%
View complete list of AXSOME THERAPEUTICS INC shareholders